Vyant Bio Inc (VYNT) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vyant Bio Inc   (NASDAQ: VYNT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Vyant Bio Inc's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vyant Bio Inc's ROI in the fourth quarter of 2022?
Vyant Bio Inc recorded a cumulative net loss of $-23 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on investment (ROI) of -125.62%.

Within the Healthcare sector 1028 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 4587 to 5744.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM -66.25 % -36.16 % 142.11 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 12 16 19 25 32
Return On Investment (TTM) -125.62 % -186.31 % -133.04 % -97.74 % -76.34 %
VYNT's Overall Ranking # 5744 # 4587 # 0 # 0 # 0
Seq. Investment Change TTM -22.24 % -30.2 % -23.75 % -18.46 % 47.09 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -23 -43 -44 -43 -41

VYNT Company Profile >> Back to VYNT Roi Comparisons >> See Annual VYNT Return On Investment



Return On Investment VYNT's Ranking
Within: No.
Industry # 50
Sector # 1029
Overall # 5744

Return On Investment Statistics
High Average Low
-29.47 %
-83.11 %
-236.01 %
(Sep 30 2014)   (Jun 30 2019)







Financial Statements
Vyant Bio Inc's IV. Quarter Investments $ 12 Millions VYNT's Balance sheet
Vyant Bio Inc's IV. Quarter Income $ -4 Millions Quarterly VYNT's Income Statement
VYNT's Income by Division See VYNT's Income by Division


VYNT Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 12 32 4 8 8
Y / Y Investment Growth -64.17 % 688.37 % -48.5 % -2.23 % -75.1 %
Net Income in Millions -23 -41 -8 -7 -20
Y / Y Net Income Growth - - - - -
Annual Return On Investment -196.62 % -126.87 % -195.86 % -84.57 % -251.12 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VYNT's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VYNT's Competitors
Subscribers only: Roi for Vyant Bio Inc's Suppliers
Subscribers only: Return On Investment for VYNT's Customers

Other Ratios
VYNT's Roa VYNT's Inventory Turnover Ratio VYNT's Growth Rates VYNT's Dividend Statistics
VYNT's Profitability Ratios VYNT's Asset Turnover Ratio VYNT's Dividend Growth
VYNT's Roe VYNT's Valuation Ratios VYNT's Financial Strength Ratios VYNT's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.